Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent insulinotropic polypeptide receptor (GIP) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels Retatrutide activates the GIP, GLP-1, and GCG receptors simultaneously, leading to better weight loss and cardiometabolic benefits compared to targeting a single receptor
These actions collectively contribute to the lowering of blood glucose levels, making GLP-1 receptor agonists like semaglutide highly effective for diabetes management
Can I take Colecalciferol and Tizanidine together
GLP-1 therapy for type 2 diabetes helps improve blood sugar control, reduce insulin resistance, promote weight loss, and lower cardiovascular risk
Recent research clearly shows that obesity is a chronic disease in its own right